These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1911358)

  • 21. Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2a.
    Nagler A; Ackerstein A; Barak V; Slavin S
    J Hematother; 1994; 3(1):75-82. PubMed ID: 7922012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.
    Guilhot F; Abgrall JF; Harousseau JL; Bauters F; Brice P; Dine G; Tilly H; Ifrah N; Cassasus P; Rochant H
    Leuk Lymphoma; 1993; 11 Suppl 1():181-3. PubMed ID: 8251893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha.
    Pawelec G; Da Silva P; Max H; Kalbacher H; Schmidt H; Bruserud O; Zügel U; Baier W; Rehbein A; Pohla H
    Leuk Lymphoma; 1995 Aug; 18(5-6):471-8. PubMed ID: 8528055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
    Kantarjian HM; Talpaz M
    Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon alfa-2a for chronic myeloid leukemia.
    Kennedy BJ
    N Engl J Med; 1994 Aug; 331(6):402. PubMed ID: 8028628
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of natural killer cells in the treatment of chronic myeloid leukemia.
    Silla LM; Whiteside TL; Ball ED
    J Hematother; 1995 Aug; 4(4):269-79. PubMed ID: 7489141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon alfa-2a for chronic myeloid leukemia.
    Mehta J
    N Engl J Med; 1994 Aug; 331(6):401; author reply 402. PubMed ID: 8068137
    [No Abstract]   [Full Text] [Related]  

  • 29. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of alpha-interferons in chronic myelogenous leukaemia.
    Talpaz M
    Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008
    [No Abstract]   [Full Text] [Related]  

  • 31. Unmaintained cytogenetic and molecular remission in chronic myelogenous leukaemia following treatment by interferon.
    Rio B; Ramond S; Lacorte JM; Pépin D; Barbu V; Viguie F; Ajchenbaum-Cymbalista F; Lorrot M; Chambaz J; Zittoun R
    Br J Haematol; 1996 Feb; 92(2):504-5. PubMed ID: 8603027
    [No Abstract]   [Full Text] [Related]  

  • 32. Conversion of interferon-induced, long-term cytogenetic remissions in chronic myelogenous leukemia to polymerase chain reaction negativity.
    Kurzrock R; Estrov Z; Kantarjian H; Talpaz M
    J Clin Oncol; 1998 Apr; 16(4):1526-31. PubMed ID: 9552062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia.
    Jootar S
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to IFN alpha in myelogenous leukaemia.
    Mahon FX; Fabères C; Reiffers J
    Lancet; 1996 Jan; 347(8993):57-8. PubMed ID: 8531561
    [No Abstract]   [Full Text] [Related]  

  • 35. Evolving approaches with interferon alfa in chronic myelogenous leukemia.
    Morra E; Alimena G; Lazzarino M; Liberati AM; Montefusco E; Bernasconi P; Mancini M; Donti E; Merante S; Caricchi P
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):26-7. PubMed ID: 8235701
    [No Abstract]   [Full Text] [Related]  

  • 36. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia.
    Itoh T; Tamura S; Takemoto Y; Kakishita E
    Int J Mol Med; 1999 Dec; 4(6):659-63. PubMed ID: 10567680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulomatous bone marrow inflammation during treatment of chronic myeloid leukaemia with interferon alpha-2b.
    Siboni A; Mourits-Andersen T; Moesner J
    J Clin Pathol; 1995 Sep; 48(9):878-80. PubMed ID: 7490329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study alternating alpha-2a-interferon and gamma-interferon therapy in patients with chronic myelogenous leukemia.
    Talpaz M; Kurzrock R; Kantarjian H; Rothberg J; Saks S; Evans L; Gutterman JU
    Cancer; 1991 Nov; 68(10):2125-30. PubMed ID: 1913450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interferon alfa-2b treatment of adult patients during early chronic phase of Ph1-positive chronic myeloid leukemia (initial report on a cooperative study, protocol CML-MIG-97)].
    Khoroshko ND; Turkina AG; Zakharova AV; Kobzev IuN; Domracheva EV; Tikhonova LIu; Semenova EA; Zhuravlev VS; Sokolova MA; Kuznetsov SV
    Ter Arkh; 1999; 71(7):42-7. PubMed ID: 10481867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
    Alimena G; Meloni G; de Cuia MR; Rondinelli MB; Lo Coco F; Montefusco E; Mancini M; Pinto R; Nanni M; Cedrone M
    Leuk Lymphoma; 1993; 11 Suppl 1():281-91. PubMed ID: 7902746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.